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Edited by Angel NebredaAbstract a-Dystroglycan (a-DG) plays a crucial role in main-
taining the stability of muscle cell membrane. Although it has
been shown that the N-terminal domain of a-DG (a-DG-N) is
cleaved by a proprotein convertase, its physiological signiﬁcance
remains unclear. We show here that native a-DG-N is secreted
by a wide variety of cultured cells into the culture media. The se-
creted a-DG-N was both N- and O-glycosylated. Finally, a small
amount of a-DG-N was detectable in the normal human serum.
These observations indicate that the cleavage of a-DG-N is a
widespread event and suggest that the secreted a-DG-N might
be transported via systemic circulation in vivo.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The dystroglycan complex is composed of two proteins, a-
and b-dystroglycan (a-and b-DG) which are encoded by a
single gene [1]. a-DG is a highly glycosylated extracellular
peripheral membrane protein and binds to several extracellular
matrix proteins including laminin, agrin and perlecan [2–4]. In
turn, the transmembrane protein b-DG anchors a-DG at the
extracellular surface of the plasma membrane [2,3]. a-DG is
composed of three distinct domains; the N-terminal, mucin-
like and C-terminal domains (Fig. 1). The N- and C-terminal
domains exhibit globular structure and are connected by the
central mucin-like domain which is highly glycosylated by O-
linked sugar chains [5].
Functional defect of a-DG is implicated in the pathogenesis
of several types of congenital muscular dystrophies, in which
aberrant glycosylation of a-DG causes severe reduction of its
laminin binding activity [6–11]. Aberrant glycosylation of a-
DG is also demonstrated in a wide range of carcinoma cells,
where it may lead to abnormal cell-extracellular matrix inter-
actions and thus contribute to invasion and metastasis of
cancer cells [12–15]. Moreover, some pathogens such as
lymphocytic choriomeningitis virus, Lassa fever virus andAbbreviations: DG, dystroglycan; a-DG-N, N-terminal domain of a-
dystroglycan; PC, proprotein convertase
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doi:10.1016/j.febslet.2008.01.006Mycobacterium leprae utilize a-DG as a receptor to invade
host cells [16,17].
Recently, it has been demonstrated that the N-terminal
domain of a-DG (a-DG-N) interacts with Large, a putative
glycosyltransferase mutated in the patients with congenital
muscular dystrophy type 1D (MDC1D) [10], and then it is
cleaved by a proprotein convertase (PC) called furin [18,19]
(Fig. 1). However, the physiological signiﬁcance of the proteo-
lytic cleavage of a-DG-N remains elusive. In the present study,
we generated a speciﬁc antibody against a-DG-N and charac-
terized its processing in cultured cells.2. Materials and methods
2.1. Antibodies
Rabbit polyclonal antibody was generated by immunizing
New Zealand white rabbits with a peptide corresponding to the
30 amino acids, 141–170, in the N-terminal domain of human
a-DG (NGSHIPQTSSVFSIEVYPEDHSDLQSVRTA). The antibody
against a-DG-N was aﬃnity puriﬁed using GST-a-DG-N (anti-a-DG-
N, AP1528) (Fig. 1). Mouse monoclonal antibody against the sugar
chain moieties of a-DG (anti-a-DG-sugar, IIH6), mouse monoclonal
antibody against the C-terminal domain of b-DG (anti-b-DG), and
rabbit polyclonal antibody against the C-terminal domain of human
a-DG (anti-a-DG-C, AP1530) were described previously [2,20]. Aﬃnity
isolated rabbit anti-laminin was obtained from Sigma–Aldrich.
2.2. Cell culture
Mouse myoblast, C2C12, African green monkey kidney, COS-7, hu-
man breast adenocarcinoma, MCF7 and human prostate carcinoma,
DU145 were purchased from American Type Culture Collection. Hu-
man cervix carcinoma, HeLa and human embryonic kidney, HEK293
were obtained from Human Science Research Resource Bank. Cells
were plated on plastic non-coated or laminin-coated culture dishes
(DB Bioscience) and cultured in Dulbeccos modiﬁed Eagles medium,
except that HeLa, MCF7 and DU145 were fed in Eagles minimal
essential medium, supplemented with 10% fetal bovine serum, 100 U/
ml penicillin G, 100 lg/ml streptomycin and 0.25 lg/ml amphotericin
B. In the case of MCF7, 0.01 mg/ml of bovine insulin was added to
the medium. For some cell lines, medium was replaced by a serum-free
one 2 to 4 days before harvesting cells. In some experiments, cells were
cultured in the presence of 200 lM of decanoyl-RVKR-CMK (Calbio-
chem), an inhibitor of PC, for 2 days. The culture medium was concen-
trated using Amicon Ultra-15 (Millipore) and the cells were lysed in
sample buﬀer (65 mM Tris–HCl, pH 6.9, 3% SDS, 1% b-mercap-
toethanol, 115 mM sucrose, 0.0004% Bromophenol blue). Materials
were separated by 5–15% SDS–PAGE and then analyzed by Western
blotting.
2.3. Lectin chromatography
The culture medium of C2C12 cells was incubated with lectin bound
agarose, including concanavalin A (Con A), lentil lectin (LCA), wheat
germ agglutinin (WGA), Ricinus communis agglutinin 120 RCA120),
Aleuria auranlia lectin (AAL), peanut agglutinin (PNA), Maackiablished by Elsevier B.V. All rights reserved.
Fig. 1. Schematic representation of human a-DG and GST-a-DG-N
fusion protein. Domain structures of a-and b-DG are shown. The
N-terminal domain of a-DG is cleaved by a proprotein convertase.
Positions of the epitopes for anti-a-DG antibodies are indicated by
black bars. SP, signal peptide.
Fig. 2. Anti-a-DG-N recognizes the N-terminal domain of a-DG
speciﬁcally. Anti-a-DG-N detected the 60 kDa band of GST-a-DG-N
fusion protein. Pre-absorption of the antibody by GST-a-DG-N fusion
protein or antigen peptide eliminated the 60 kDa band completely.
Pre-absorption of the antibody by GST protein or irrelevant control
peptide did not eliminate the 60 kDa band. The 60 kDa band was not
detected by anti-a-DG-C, anti-a-DG-sugar or anti-b-DG, while it was
detected by anti-GST antibody. Molecular mass standards (D · 103)
are shown on the left. CB, Coomassie blue staining of the gel.
440 F. Saito et al. / FEBS Letters 582 (2008) 439–444amurensis lectin (MAM), Sambucus sieboldiana agglutinin (SSA), phy-
tohemagglutinin-E4, (PHA-E4) (Seikagaku Corporation) and Jacalin
(Vector). The void fractions were analyzed by Western blotting using
anti-a-DG-N.
2.4. Miscellaneous
For construction of a GST fusion protein, human DAG1 gene (Gen-
Bank accession number NM 004393) corresponding to a-DG-N (ami-
no acid 30–316) was ampliﬁed by PCR and subcloned into pGEX-2TK
expression vector (GE healthcare) (Fig. 1). GST-a-DG-N fusion pro-
tein was expressed by Escherichia coli and puriﬁed as described previ-
ously [21]. Chemical deglycosylation was performed as described
elsewhere [2,22]. Western blotting and laminin overlay assay were de-
scribed previously [11]. Human sera were obtained from the members
of the laboratory according to the standard protocol. Albumin concen-
tration in the sera was reduced using ProteoSeek Albumin/IgG Re-
moval Kit (Pierce).Fig. 3. Native a-DG-N is secreted into culture medium. The culture
medium of C2C12 cells was analyzed by Western blotting using anti-a-
DG-N. The antibody detected an intense and broad band of a-DG-N
with an apparent molecular mass of 37 kDa, which was eliminated
completely by pre-absorption of the antibody by antigen peptide or
GST-a-DG-N fusion protein. The 37 kDa band increased progres-
sively from 0 to 72 h of cell culture. There was no signiﬁcant diﬀerence
in the level of secretion of a-DG-N between the C2C12 cells cultured
on the control plastic culture dishes and laminin-coated dishes. a-DG-
N was also detected in the culture medium of a wide variety of cell
lines, including HEK293, COS-7, HeLa, MCF7 and DU145. Molec-
ular mass standards (D · 103) are shown on the left.3. Results
3.1. Characterization of the antibody against a-DG-N
We characterized the speciﬁcity of the antibody against
a-DG-N (anti-a-DG-N) by Western blotting using GST-a-
DG-N fusion protein. Anti-a-DG-N detected the 60 kDa band
of GST-a-DG-N fusion protein (Fig. 2). Pre-absorption of the
antibody by GST-a-DG-N fusion protein or antigen peptide
eliminated the 60 kDa band completely (Fig. 2). On the other
hand, pre-absorption of the antibody by GST protein or irrel-
evant control peptide did not eliminate the 60 kDa band
(Fig. 2). The 60 kDa band was not detected by anti-a-DG-C,
anti-a-DG-sugar, or anti-b-DG, while it was detected by
anti-GST antibody. These data conﬁrm the speciﬁc recognition
of a-DG-N by this antibody.
3.2. Native a-DG-N is secreted into culture media by cultured
cells
In the previous report, it was demonstrated that the over-
expressed Fc-tagged a-DG was cleaved by a PC [18]. To see
if native a-DG-N is cleaved by a PC and released from the cell
surface, we analyzed the culture medium of C2C12 cells by
Western blotting. Interestingly, anti-a-DG-N detected an in-
tense and broad band with an apparent molecular mass of
37 kDa in the culture medium (Fig. 3). This band was elimi-
nated completely by pre-absorption of the antibody by antigen
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the 37 kDa band increased progressively from 0 to 72 h of cell
culture (Fig. 3). These results indicate that the 37 kDa protein
is a-DG-N secreted from C2C12 cells into the culture medium.
Closer inspection of the blots revealed that the broad 37 kDa
band was composed of multiple bands with slightly diﬀerent
molecular masses (Fig. 3). To see if the interaction of a-DG
with laminin may aﬀect the secretion of a-DG-N, we also cul-
tured C2C12 cells on the culture dishes coated with laminin. As
shown in the right middle panel of Fig. 3, there was no signif-
icant diﬀerence in the level of secretion of a-DG-N between the
control plastic dishes and laminin-coated dishes. We also
examined if cell lines other than C2C12 secrete a-DG-N into
culture medium. Western blotting demonstrated that a wide
variety of cell lines including HEK293, COS-7, HeLa, MCF7
and DU145 secreted a-DG-N (Fig. 3). Interestingly, the molec-
ular mass of a-DG-N varied considerably among diﬀerent cell
lines (Fig. 3). In particular, a-DG-N secreted by HeLa cells mi-
grated around 45 kDa, slower than the other cell lines (Fig. 3).
3.3. Native a-DG-N is cleaved by a PC in C2C12 cells
To see if native a-DG-N is cleaved by a PC in C2C12 cells,
we cultured C2C12 cells in the presence or absence of CMK, a
PC inhibitor, and analyzed the cell lysate and culture medium
by Western blotting. When the cells were cultured in the
absence of CMK, a-DG with a molecular mass of 125 kDa
was detected in the cell lysate by the antibody against the sugar
chain moieties of a-DG (anti-a-DG-sugar, IIH6) and the anti-
body against the C-terminal domain of a-DG (anti-a-DG-C),
as well as by laminin overlay assay (Fig. 4, upper panel). How-
ever, anti-a-DG-N did not react with this 125 kDa a-DG mol-Fig. 4. Native a-DG-N is cleaved by a PC in C2C12 cells. C2C12 cells were cu
culture medium were analyzed. When the cells were cultured in the absence of
lysate by the antibody against the sugar chain moieties of a-DG (anti-a-DG-s
DG-C), as well as by laminin overlay assay (LAM O/L). Anti-a-DG-N did no
in the presence of CMK, anti-a-DG-N, anti-a-DG-sugar and anti-a-DG-C, as
of 160 kDa. When the cells were cultured in the absence of CMK, a 37 kDa ba
not detectable when the cells were cultured in the presence of CMK. This 37 k
either in the absence or presence of CMK. The 37 kDa a-DG-N in the culture
in laminin overlay assay. The expression of b-DG in the cell lysate was not
LAM O/L, laminin overlay. Molecular mass standards (D · 103) are shownecule (Fig. 4, upper panel). When the cells were cultured in the
presence of CMK, anti-a-DG-N, anti-a-DG-sugar and anti-
a-DG-C, as well as laminin overlay assay, all detected a-DG
with a molecular mass of 160 kDa (Fig. 4, upper panel).
When the cells were cultured in the absence of CMK, a
37 kDa band was detected in the culture medium by anti-
a-DG-N (Fig. 4, lower panel). However, this band was unde-
tectable when the cells were cultured in the presence of
CMK (Fig. 4, lower panel). The 37 kDa band was not detected
in the cell lysate by anti-a-DG-N either in the absence or pres-
ence of CMK (Fig. 4, upper panel). These results indicate that
native a-DG-N is excised by a PC and secreted into the culture
medium immediately upon cleavage (Fig. 1). The secreted
a-DG-N did not react with anti-a-DG-sugar and did not bind
laminin in laminin overlay assay (Fig. 4, lower panel).
Fragments of a-DG suggestive of processing other than that
of a-DG-N were not detected by anti-a-DG-C either in the cell
lysate or culture medium (Fig. 4). As expected, the expression
of b-DG in the cell lysate was not aﬀected by CMK (Fig. 4,
upper panel) and b-DG was not detected in the cell culture
medium (Fig. 4, lower panel).
3.4. a-DG-N is both N- and O-glycosylated
To assess the status of glycosylation of a-DG-N, we per-
formed enzymatic deglycosylation of cell culture medium. As
described above, the molecular mass of a-DG-N was 37 kDa
in C2C12 and 45 kDa in HeLa cell culture medium, respec-
tively. Digestion by N-Glycosidase F decreased the molecular
mass of a-DG-N by 5 kDa in both C2C12 and HeLa cell cul-
ture medium (Fig. 5A). On the other hand, digestion by neur-
aminidase decreased the molecular mass of a-DG-N by 3 kDaltured in the presence or absence of CMK, and then the cell lysate and
CMK, a-DG with a molecular mass of 125 kDa was detected in the cell
ugar) and the antibody against the C-terminal domain of a-DG (anti-a-
t react with the 125 kDa a-DG molecule. When the cells were cultured
well as laminin overlay assay, all detected a-DG with a molecular mass
nd was detected in the culture medium by anti-a-DG-N. This band was
Da band was not detected in the cell lysate when the cells were cultured
medium did not react with anti-a-DG-sugar and did not bind laminin
aﬀected by CMK and b-DG was not detected in the culture medium.
on the left.
Fig. 5. a-DG-N is both N- and O-glycosylated. (A) The status of
glycosylation of a-DG-N was analyzed by enzymatic deglycosylation.
As described above, the molecular mass of a-DG-N was 37 kDa in
C2C12 and 45 kDa in HeLa cell culture medium, respectively.
Digestion by N-glycosidase F decreased the molecular mass of a-
DG-N by 5 kDa in both C2C12 and HeLa cell culture medium.
Digestion by neuraminidase decreased the molecular mass of a-DG-N
by 3 kDa in C2 C12 and 8 kDa in HeLa cell culture medium,
respectively. Digestion by neuraminidase together with O-glycosidase
decreased the molecular mass of a-DG-N by 4 kDa in C2 C12 and
12 kDa in HeLa cell culture medium, to the ﬁnal molecular mass of
33 kDa in both. Molecular mass standards (D · 103) are shown on the
left. (B) The sugar chain moieties of a-DG-N in the culture medium of
C2C12 cells were analyzed by lectin column chromatography. The
amount of a-DG-N remaining in the void fraction was decreased by
incubation with Con-A and LCA column, but not other lectins.
Fig. 6. a-DG-N is detectable in the normal human serum. Normal
human sera were analyzed by Western blotting after depletion of
albumin. Anti-a-DG-N detected a band with a molecular mass of
40 kDa (arrowhead), which was completely eliminated by pre-absorp-
tion of the antibody by antigen peptide or GST-a-DG-N fusion
protein. This band was not detected by anti-a-DG-C or anti-a-DG-
sugar. This 40 kDa band was detectable in all of the six other normal
control sera. Molecular mass standards (D · 103) are shown on the
left.
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(Fig. 5A). Finally, digestion by neuraminidase together with
O-glycosidase decreased the molecular mass of a-DG-N by
4 kDa in C2 C12 and 12 kDa in HeLa cell culture medium
to the ﬁnal molecular mass of 33 kDa in both (Fig. 5A). These
data demonstrate that a-DG-N is both N- and O-glycosylated
and indicate that diﬀerential glycosylation is at least partly
responsible for the diﬀerence in its molecular mass between
C2C12 and HeLa cell culture medium observed before degly-
cosylation. We further attempted to characterize the sugar
chain moieties of a-DG-N in the culture medium of C2C12
cells by lectin column chromatography. The amount of
a-DG-N remaining in the void fraction was decreased by incu-
bation with Con-A and LCA column, but not other lectins
(Fig. 5B). These results suggest that native a-DG-N may pos-
ses N-linked glycans of high-mannose type and N-linked gly-
cans of hybrid type with or without a1ﬁ 6 linked fucose to
the reducing terminal GlcNAc.
3.5. a-DG-N is detectable in the normal human serum
The aforementioned results raised an intriguing possibility
that a-DG-N may be secreted in the human body ﬂuid
in vivo. To test this possibility, we analyzed normal human
sera by Western blotting using anti-a-DG-N. When the wholesera were analyzed, detection of bands by Western blotting
was severely hindered by the presence of huge amount of albu-
min (data not shown). So we reduced the albumin concentra-
tion of the sera before analysis as described in Section 2.
Interestingly, anti-a-DG-N detected a band with a molecular
mass of 40 kDa, which was completely eliminated by pre-
absorption of the antibody by antigen peptide or GST-a-
DG-N fusion protein (Fig. 6). In addition, this band was not
detected by other antibodies, including anti-a-DG-C and
anti-a-DG-sugar (Fig. 6). Altogether, these results indicated
speciﬁc recognition of the band by anti-a-DG-N. Further-
more, the 40 kDa band corresponding to a-DG-N was detect-
able in all the normal human sera we tested (Fig. 6, lower
panel). These results indicate that a small amount of a-DG-
N is present in the normal human serum.4. Discussion
In the previous report, TSA201 cells were transfected with
Fc-a-DG fusion protein and then cultured in the presence or
absence of CMK [18]. The overexpressed fusion protein was
puriﬁed by protein A beads and analyzed by Western blotting
[18]. Fc-a-DG fusion protein did not react with the antibody
against the N-terminal domain of a-DG when the cells were
cultured in the absence of CMK [18]. When the cells were cul-
tured in the presence of CMK, however, Fc-a-DG fusion pro-
tein migrated slower and became reactive with the antibody
F. Saito et al. / FEBS Letters 582 (2008) 439–444 443[18]. In another report, the EpH4 cells were cultured in the
presence or absence of CMK and the surface membrane pro-
teins were biotinylated, immunoprecipitated by anti-b-DG
antibody and then analyzed by Western blotting using strepta-
vidin-HRP [19]. When the cells were cultured in the presence of
CMK, a-DG which was co-immunoprecipitated with b-DG
migrated slower and a 37 kDa band appeared upon digestion
of this co-immunoprecipitates by furin, suggesting that the
37 kDa band might represent the N-terminal domain of a-
DG [19]. Although these observations indicate that a-DG-N
is cleaved by a PC, the native molecule of a-DG-N has not
yet been identiﬁed using speciﬁc antibodies and it remains elu-
sive whether the excised a-DG-N is secreted from cells or re-
tained at the cell surface via interaction with certain cell
surface molecules. In addition, it remains unclear if this prote-
olytic cleavage occurs in a wide variety of tissues ubiquitously
or in limited tissues under limited conditions in vivo. In the
present study, using a speciﬁc antibody against a-DG-N, we
have demonstrated for the ﬁrst time that native a-DG-N is se-
creted from the cultured cells into the culture medium immedi-
ately after cleavage by a PC. In addition, secretion of a-DG-N
was observed in a wide variety of cell lines, suggesting that it
might be a widespread event in vivo. This is consistent with
the ﬁndings that both a-DG and furin are expressed ubiqui-
tously [1,23].
A recent study on the crystal structure of recombinant a-DG
revealed autonomous domains in a-DG-N [24]. The structure
is characterized by an Ig-like domain and a domain resembling
ribosomal RNA-binding proteins, connected by a long and
ﬂexible linker [24]. a-DG-N contains a consensus sequence
for N-glycosylation at amino acid 139 [25]. By enzymatic
deglycosylation, we have shown that a-DG-N in the culture
medium of C2C12 or HeLa cells is actually N-glycosylated.
Moreover, lectin chromatography suggested that a-DG-N is
modiﬁed by N-linked glycans of high-mannose type and hy-
brid type. The mucin-like domain of a-DG is well known to
be extensively and diﬀerentially O-glycosylated. Interestingly,
our results of enzymatic deglycosylation indicate that a-DG-
N is also modiﬁed by O-linked glycans diﬀerentially. Among
the O-linked glycans of a-DG, O-mannosyl glycans play a crit-
ical role in the binding with laminin [26]. As judged from the
results of laminin overlay assay, however, a-DG-N does not
seem to possess the O-mannosyl glycan structure involved in
the binding of laminin.
In the present study, we have shown that a 40 kDa band cor-
responding to a-DG-N is detectable in the normal human ser-
um after depletion of albumin. The results indicate that a small
amount of a-DG-N is present in the normal human serum and
raise a possibility that a-DG-N might be secreted in the human
serum in vivo. One of the important roles of a-DG-N is inter-
action with Large [18]. Mutant a-DG molecule lacking the
N-terminal domain from the beginning does not bind laminin,
because it can not interact with Large and thus glycosylation
necessary for laminin binding does not proceed in the mucin-
like domain [18]. However, the cleavage of a-DG-N itself does
not seem to be essential for the function of a-DG in terms of
laminin binding activity, because inhibition of cleavage by
CMK dose not aﬀect the laminin binding activity of a-DG it-
self [18]. In contrast, other substrates for furin, including
growth factors, hormones or receptors, are initially synthesized
as inactive proproteins, which are then processed to become
the biologically active mature proteins by proteolytic cleavage[23]. Taking these observations into account, it is possible that
the secreted a-DG-N, but not the membrane bound a-DG con-
sisting of mucin-like and C-terminal domains, may be acti-
vated and new functional roles may be conferred by this
cleavage. It should be noted, in this respect, that recombinant
a-DG-N was shown to promote neurite extension of PC 12
cells [27]. In the present study, we have demonstrated the pres-
ence of a small amount of a-DG-N in the normal human ser-
um. One intriguing possibility is that the secreted a-DG-N
might be transported via systemic circulation and might exert
hitherto unidentiﬁed eﬀects at unidentiﬁed target organs
in vivo. Another intriguing possibility is that the amount of
a-DG-N in the serum might be altered in certain neuromuscu-
lar disorders such as a-dystroglycanopathy. Further studies
are needed to clarify these points.
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